A Phase II Study of Capecitabine and Oxaliplatin With Radiation for Esophageal and Gastroesophageal Junction Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2018
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 17 Jul 2018 Status changed from active, no longer recruiting to completed.
- 16 Nov 2016 Planned End Date changed from 1 Feb 2015 to 1 Feb 2019.
- 16 Nov 2016 Planned primary completion date changed from 1 Feb 2015 to 1 Feb 2018.